Teva And Alvotech Confirm Quallent Deal On US Adalimumab

Follows Announcement By Cigna’s Evernorth Of $0 Out-Of-Pocket Scheme For Biosimilar

 
• By David Wallace
Handshake of businessmen
Alvotech and Teva have confirmed their deal with Quallent

More from Deals

More from Business